Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocel
![Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent](https://www.frontiersin.org/files/Articles/748936/fphar-12-748936-HTML/image_m/fphar-12-748936-g001.jpg)
Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development
![Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent](https://www.frontiersin.org/files/Articles/748936/fphar-12-748936-HTML/image_m/fphar-12-748936-g003.jpg)
Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
![Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent](https://www.frontiersin.org/files/Articles/748936/fphar-12-748936-HTML/image_m/fphar-12-748936-g002.jpg)
Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development
![High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer - Article abstract #903248 | Medical Science Monitor High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer - Article abstract #903248 | Medical Science Monitor](https://jours.isi-science.com/image.php?i=903248.jpg&w=155&idJour=87&mode=min)
High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer - Article abstract #903248 | Medical Science Monitor
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development
![Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent](https://www.frontiersin.org/files/Articles/748936/fphar-12-748936-HTML/image_m/fphar-12-748936-g005.jpg)
Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
![Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent Frontiers | Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent](https://www.frontiersin.org/files/Articles/748936/fphar-12-748936-HTML/image_m/fphar-12-748936-g004.jpg)